Submission of clinical materials required by laboratories.
Effective Dec 17, 201845 SDR 83Source: 38 SDR 8, effective August 1, 2011; 42 SDR 77, effective November 30, 2015; 45 SDR 83, effective December 17, 2018. | General Authority: SDCL 34-1-17 , 34-22-9 , 34-22-12. | Law Implemented: SDCL 34-22-9 , 34-22-12.
Laboratories must submit isolates or, if an isolate is not available, laboratories must submit material containing the infectious agent to the South Dakota Public Health Laboratory for the following:
- (1) Anthrax (Bacillus anthracis);
- (2) Brucellosis (Brucella spp.);
- (3) Candidiasis (Candida auris);
- (4) Carbapenem-resistant Enterobacteriaceae;
- (5) Diphtheria (Corynebacterium diphtheriae);
- (6) Haemophilus influenzae type b, invasive;
- (7) Novel Influenza A;
- (8) Listeriosis (Listeria monocytogenes);
- (9) Meningococcal disease, invasive (Neisseria meningitidis);
- (10) Plague (Yersinia pestis);
- (11) Salmonellosis (Salmonella spp.);
- (12) Shiga toxin-producing Escherichia coli
- (STEC) ;
- (13) Shigellosis (Shigella spp.);
- (14) Smallpox (Variola);
- (15) Tuberculosis (Mycobacterium tuberculosis and Mycobacterium bovis);
- (16) Tularemia (Francisella tularensis);
- (17) Typhoid (Salmonella typhi); and
- (18) Vancomycin-resistant Staphylococcus aureus
- (VRSA) .
Source: 38 SDR 8, effective August 1, 2011; 42 SDR 77, effective November 30, 2015; 45 SDR 83, effective December 17, 2018.
General Authority: SDCL 34-1-17 , 34-22-9 , 34-22-12.
Law Implemented: SDCL 34-22-9 , 34-22-12.
Prior versions effective: 2015-11-30, 2011-08-01.